EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts

Daniel G P Turner, Willem J De Lange, Yanlong Zhu, Christopher L Coe iD, Judith Simcox, Ying Ge, Timothy J Kamp iD, J Carter Ralphe, Alexey V Glukhov iD

The Journal of Physiology · 2024

DOI: 10.1113/jp284807 ↗

At a glance

Journal article in The Journal of Physiology, 2024. Written by Daniel G P Turner and 8 co-authors. Institution: Department of Medicine, Cardiovascular Medicine, University of Wisconsin-Madison, Madison, WI, USA. Major MEDLINE topics: Sphingomyelin Phosphodiesterase, Tissue Engineering, Myocytes, Cardiac, Mechanotransduction, Cellular. Cited 10 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS, NIA NIH HHS, NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cardiovascular disease is the leading cause of death in the USA and is known to be exacerbated by elevated mechanical stress from hypertension. Caveolae are plasma membrane structures that buffer mechanical stress but have been found to be reduced in pathological conditions associated with chronically stretched myocardium. To explore the physiological implications of the loss of caveolae, we used human engineered cardiac tissue (ECT) constructs, composed of human induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes and hiPSC‐derived cardiac fibroblasts, to develop a long‐term cyclic stretch protocol that recapitulates the effects of hypertension on caveolae expression, membrane tension, and the β‐adrenergic response. Leveraging this new stretch protocol, we identified neutral sphingomyelinases (nSMase) as mechanoregulated mediators of caveolae loss, ceramide production and the blunted β‐adrenergic response in this human cardiac model. Specifically, in our ECT model, nSMase inhibition via GW4869 prevented stretch‐induced loss of caveolae‐like structures, mitigated nSMase‐dependent ceramide production, and maintained the ECT contractile kinetic response to isoprenaline. These findings are correlated with a blood lipidomic analysis in middle‐aged and older adults, which revealed an increase of the circulating levels of ceramides in adults with hypertension. Furthermore, we found that conduction slowing from increased pressure loading in mouse left ventricle was abolished in the context of nSMase inhibition. Collectively, these findings identify nSMase as a potent drug target for mitigating stretch‐induced effects on cardiac function. image Key points We have developed a new stretch protocol for human engineered cardiac tissue that recapitulates changes in plasma membrane morphology observed in animal models of pressure/volume overload. Stretch of engineered cardiac tissue induces activation of neutral sphingomyelinase (nSMase), generation of ceramide, and disassembly of caveolae. Activation of nSMase blunts cardiac β‐adrenergic contractile kinetics and mediates stretch‐induced slowing of conduction and upstroke velocity. Circulating ceramides are increased in adults with hypertension, highlighting the clinical relevance of stretch‐induced nSMase activity.

Subjects

MeSH terms (MEDLINE)

Sphingomyelin PhosphodiesteraseTissue EngineeringMyocytes, CardiacMechanotransduction, CellularInduced Pluripotent Stem CellsCeramidesHumansAnimalsMiceMaleCaveolaeBenzylidene CompoundsAniline CompoundsIsoproterenolMyocardiumMiddle Aged

Author keywords

caveolaeceramidehypertensionneutral sphingomyelinasestretchtissue engineering

Substances

Sphingomyelin PhosphodiesteraseCeramidesGW 4869Benzylidene CompoundsAniline CompoundsIsoproterenol

Authors and institutions

  • Department of Medicine, Cardiovascular Medicine, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Pediatrics, Pediatric Cardiology, University of Wisconsin-Madison, Madison, WI, USA.
  • Human Proteomics Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Psychology, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA.

ORCID profiles: Christopher L Coe, Timothy J Kamp, Alexey V Glukhov

Funding

  • NHLBI NIH HHS
  • NIA NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIH HHS
  • National Heart, Lung, and Blood Institute
  • American Heart Association
  • National Institute of General Medical Sciences

Cite

APA

Turner, D. G. P., De Lange, W. J., Zhu, Y., Coe, C. L., Simcox, J., Ge, Y., Kamp, T. J., Ralphe, J. C., & Glukhov, A. V. (2024). Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts. The Journal of Physiology. https://doi.org/10.1113/jp284807

Vancouver

Turner DGP, De Lange WJ, Zhu Y, Coe CL, Simcox J, Ge Y, et al. Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts. The Journal of Physiology. 2024. doi:10.1113/jp284807

BibTeX
@article{Turner2024,
  author = {Turner, Daniel G P and De Lange, Willem J and Zhu, Yanlong and Coe, Christopher L and Simcox, Judith and Ge, Ying and Kamp, Timothy J and Ralphe, J Carter and Glukhov, Alexey V},
  title = {Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts},
  journal = {The Journal of Physiology},
  year = {2024},
  doi = {10.1113/jp284807}
}
Start for free →